Literature DB >> 1972433

Similarities in intestinal humoral immunity in dermatitis herpetiformis without enteropathy and in coeliac disease.

S O'Mahony1, J P Vestey, A Ferguson.   

Abstract

Intestinal humoral immunity was examined in eight patients with dermatitis herpetiformis and normal jejunal histology (as determined by quantitative morphometry) on a gluten-containing diet. Jejunal aspirate was taken at the time of jejunal biopsy, and levels of total immunoglobulins (IgA, IgM, IgG) and specific antibody to gliadin and two other dietary proteins, betalactoglobulin and ovalbumin, were measured. The pattern of secretory immune responses in the dermatitis herpetiformis patients was similar to that in twenty-six patients with untreated coeliac disease--ie, higher than normal concentrations of IgA, IgM, and IgG and high levels of specific antibodies (IgA and IgM) to the three dietary proteins. Serum levels of IgA antigliadin were similar in the dermatitis herpetiformis and control (twenty-eight patients who underwent jejunal biopsy to exclude coeliac disease) groups, and serum levels of IgG antigliadin were intermediate between those of the control and coeliac disease groups. These findings suggest that investigation of gut humoral immunity may provide a diagnostic index of latent coeliac disease. The definition of coeliac disease as a permanent gluten-sensitive enteropathy may have to be revised if the proposed two-stage model is confirmed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1972433     DOI: 10.1016/0140-6736(90)93029-o

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  15 in total

1.  Do adults with high gliadin antibody concentrations have subclinical gluten intolerance?

Authors:  J A Arnason; H Gudjónsson; J Freysdóttir; I Jónsdóttir; H Valdimarsson
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

2.  Increase in gamma/delta T cell receptor bearing lymphocytes in normal small bowel mucosa in latent coeliac disease.

Authors:  M Mäki; K Holm; P Collin; E Savilahti
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

3.  Bone mass and metabolism in dermatitis herpetiformis.

Authors:  M Di Stefano; R A Jorizzo; G Veneto; L Cecchetti; G Gasbarrini; G R Corazza
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

4.  Small intestine in lymphocytic and collagenous colitis: mucosal morphology, permeability, and secretory immunity to gliadin.

Authors:  P Moayyedi; S O'Mahony; P Jackson; D A Lynch; M F Dixon; A T Axon
Journal:  J Clin Pathol       Date:  1997-06       Impact factor: 3.411

Review 5.  Clinical and pathological spectrum of coeliac disease--active, silent, latent, potential.

Authors:  A Ferguson; E Arranz; S O'Mahony
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

6.  Screening for coeliac disease: the meaning of low titers of anti-gliadin antibodies (AGA) in non-coeliac children.

Authors:  M Bonamico; G Ballati; P Mariani; M Latini; P Triglione; I Rana; E Porro; M A Mesturino; S Criscione
Journal:  Eur J Epidemiol       Date:  1997-01       Impact factor: 8.082

7.  Immunohistochemical changes in the jejunum in first degree relatives of patients with coeliac disease and the coeliac disease marker DQ genes. HLA class II antigen expression, interleukin-2 receptor positive cells and dividing crypt cells.

Authors:  K Holm; E Savilahti; S Koskimies; V Lipsanen; M Mäki
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

8.  Intestinal antibody pattern of coeliac disease: association with gamma/delta T cell receptor expression by intraepithelial lymphocytes, and other indices of potential coeliac disease.

Authors:  E Arranz; J Bode; K Kingstone; A Ferguson
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

9.  Animal model of gluten induced enteropathy in mice.

Authors:  R Troncone; A Ferguson
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

Review 10.  Between celiac disease and irritable bowel syndrome: the "no man's land" of gluten sensitivity.

Authors:  Elena F Verdu; David Armstrong; Joseph A Murray
Journal:  Am J Gastroenterol       Date:  2009-06       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.